av/celyad-oncology-sa--big.svg

COM:CELYAD

Celyad Oncology

  • Stock

EUR

Last Close

0.65

25/11 09:13

Market Cap

11.14M

Beta: -

Volume Today

8.74K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
146K
-
3K
97.95%
8.52M
284,000%
3.54M
58.47%
3.12M
12.01%
6K
99.81%
5K
16.67%
102K
-
cost of revenue
115K
-
6.38M
5,449.57%
53K
99.17%
515K
871.70%
69K
-
gross profit
31K
-
-6.38M
20,677.42%
8.47M
232.78%
3.02M
64.29%
3.12M
2.98%
6K
99.81%
5K
16.67%
33K
-
selling and marketing expenses
394K
-
891K
126.14%
728K
18.29%
761K
4.53%
676K
11.17%
607K
10.21%
454K
25.21%
general and administrative expenses
5.02M
-
7.23M
44.14%
9.74M
34.77%
9.31M
4.45%
10.39M
11.57%
8.72M
16.00%
8.99M
3.09%
9.66M
7.45%
10.34M
6.95%
selling general and administrative expenses
5.02M
-
7.23M
44.14%
9.74M
34.77%
9.31M
4.45%
10.39M
11.57%
8.72M
16.00%
8.99M
3.09%
9.66M
7.45%
10.34M
6.95%
6.03M
41.69%
research and development expenses
15.87M
-
5.90M
62.82%
27.68M
369.15%
22.91M
17.22%
23.58M
2.92%
25.23M
7.02%
21.59M
14.43%
20.77M
3.79%
18.93M
8.88%
4.60M
75.69%
other expenses
-963K
-
-222K
76.95%
-2.52M
1,036.49%
-23.79M
843.00%
7.32M
130.77%
-4.58M
162.53%
-4.34M
5.16%
-3.53M
18.72%
-9.00M
155.09%
cost and expenses
20.03M
-
29.68M
48.13%
34.13M
15.02%
30.14M
11.69%
41.28M
36.96%
29.38M
28.84%
26.24M
10.67%
26.91M
2.53%
20.26M
24.70%
10.70M
47.20%
operating expenses
19.92M
-
29.68M
48.99%
34.08M
14.84%
29.63M
13.06%
41.28M
39.34%
29.38M
28.84%
26.24M
10.67%
26.91M
2.53%
20.26M
24.70%
10.63M
47.54%
interest expense
22K
-
236K
972.73%
207K
12.29%
4.45M
2,051.69%
62K
98.61%
343K
453.23%
297K
13.41%
255K
14.14%
197K
22.75%
84K
57.36%
ebitda
-18.04M
-
-27.84M
54.32%
-21.89M
21.39%
-16.66M
23.87%
-37.37M
124.21%
-27.45M
26.54%
-24.19M
11.87%
-25.58M
5.73%
-18.81M
26.46%
-10.60M
43.67%
operating income
-16.44M
-
-29.67M
80.52%
-25.61M
13.69%
-52.88M
106.47%
-38.17M
27.81%
-29.37M
23.05%
-26.24M
10.67%
-26.39M
0.58%
-40.86M
54.81%
-10.60M
74.06%
depreciation and amortization
870K
-
1.03M
18.74%
1.52M
46.76%
9.00M
493.93%
805K
91.06%
1.92M
138.88%
2.05M
6.45%
813K
60.28%
22.05M
2,611.69%
total other income expenses net
3.18M
-
252K
92.07%
1.34M
430.56%
-26.27M
2,065.07%
743K
102.83%
733K
1.35%
9.04M
1,132.61%
-111K
101.23%
-13K
88.29%
2.09M
16,146.15%
income before tax
-16.45M
-
-29.11M
76.95%
-23.61M
18.90%
-56.40M
138.84%
-37.43M
33.64%
-28.64M
23.48%
-17.20M
39.93%
-26.50M
54.05%
-40.87M
54.21%
-8.51M
79.18%
income tax expense
-2.48M
-
-55K
97.78%
-6K
89.09%
-1K
83.33%
-1.11M
111,300%
-8K
99.28%
297K
3,812.50%
10K
96.63%
65K
550%
-63K
196.92%
net income
-16.45M
-
-29.11M
76.95%
-23.61M
18.92%
-56.40M
138.90%
-36.31M
35.61%
-28.63M
21.15%
-17.50M
38.88%
-26.51M
51.49%
-40.94M
54.40%
-8.45M
79.36%
weighted average shs out
6.75M
-
8.48M
25.65%
9.31M
9.81%
9.62M
3.33%
11.14M
15.75%
12.52M
12.43%
13.94M
11.33%
15.60M
11.92%
22.59M
44.80%
weighted average shs out dil
6.75M
-
8.49M
25.74%
9.33M
9.92%
9.62M
3.14%
11.14M
15.75%
12.52M
12.43%
13.94M
11.33%
15.60M
11.92%
22.59M
44.80%
eps
-2.44
-
-3.43
40.57%
-2.53
26.24%
-5.86
131.62%
-3.26
44.37%
-2.29
29.75%
-1.26
44.98%
-1.70
34.92%
-1.81
6.47%
-0.33
81.77%
epsdiluted
-2.44
-
-3.43
40.57%
-2.53
26.24%
-5.86
131.62%
-3.26
44.37%
-2.29
29.75%
-1.26
44.98%
-1.70
34.92%
-1.81
6.47%
-0.33
81.77%

All numbers in EUR (except ratios and percentages)